MTI provides its guide to the latest young up-starts in Medtech.
Test it out
Cambridge-based Inivata has developed a simple blood test which allows for ctDNA analysis - a way for oncologists to detect cancer, stratify patients, and monitor individual response to treatment.
The non-invasive liquid biopsy could change the way that cancer is detected and monitored, providing the potential for frequent tumour profiling and personalised treatment.
Just like the real thing
Medical-X is a young company specialising in the manufacture and sale of high-fidelity patient simulators. The group opened its new factory just last year, and since then has been producing a variety of models, including Adam-X – a male patient simulator designed for practicing skills and providing medical assistance in case of emergency. He may not have a human brain, but Adam comes with a wireless computer, which allows the instructor to monitor and make adjustments in the course of the training.
Have heart
CorFigo is a startup which has recently launched its first product, Heartpad - a device intended for ablation of cardiac tissue from an epicardial (outer surface of the heart) location, while simultaneously protecting adjacent structures from unintentional ablation injury. Designed for minimally invasive ablation, the proprietary technology utilises potent cryothermal energy coupled with sophisticated sensor technology. The intended result of the Heartpad design is the efficient ablation of broad areas of cardiac tissue.
Alive and kicking
Freefoot is another new product. This new foot brace is a dynamic Ankle Foot Orthotic (AFO) that allows dorsiflexion (upwards movements of the foot) using spring resistance. The brace assists the user in raising and lowering their foot for a comfortable and natural walking motion, while providing ankle stability and foot support to keep from tripping or falling. The group says that it stands apart from alternatives on the market due to its substantially lower cost and its discreet design.
